Glaucoma, Suspect, Adult Clinical Presentation
- Author: Robert H Graham, MD; Chief Editor: Hampton Roy Sr, MD more...
History
- Patients do not usually experience any symptoms. Intermittent headaches, haloes, and blurred vision may suggest risk for angle-closure glaucoma.
- Ocular history includes the following ocular conditions that have been implicated as risk factors for developing glaucoma[12, 13] :
- Myopia
- Risk factor for glaucoma
- Disc evaluation difficult (myopic fundus, tilted disc)
- Visual field testing more difficult (fundus abnormalities, refraction-related inaccuracies)
- Pseudoexfoliation - Increases with advanced age
- Pigment dispersion (25-50% risk of developing glaucoma)
- Ocular trauma
- Glaucoma in one eye
- Associated with increased risk of future damage in the other eye
- Development of visual field defects in an average of 5 years in about 29% of untreated undamaged fellow eyes
- History of uveitis/inflammatory ocular disease
- Congenital anomalies
- Prior eye surgery
- Retinal vascular occlusion - In individuals who are susceptible, increased IOP is associated with a risk of developing central retinal vein occlusion (CRVO).
- Current or past use of steroids
- Topical steroids may elevate pressure in certain individuals.
- Optic nerve damage may be residual from previous increased IOP associated with steroid use.
- The elevation of IOP is usually seen within a few weeks of starting topical steroids.
- Myopia
- Systemic history includes the following conditions that have been associated as risk factors for developing glaucoma[12, 13] :
- Low blood pressure - Also includes overmedication of systemic hypertension
- A previous episode of hypotensive shock, trauma, vascular surgery, or hemorrhage can be significant; it may indicate that optic nerve damage is not progressive but may have been a onetime insult.
- History of vasospastic disorders - A higher prevalence of migraine headaches and Raynaud syndrome exists with normal-tension glaucoma.
- Medications
- In individuals who are susceptible, steroids may cause a rise in IOP.
- Anticholinergics (antihistamine and antipsychotics) may precipitate angle-closure glaucoma.
- Cardiovascular disease may be a factor in low-tension glaucoma.
- Hypertension
- Diabetes mellitus
- Small association
- Some studies have reported a higher prevalence of increased mean IOP and POAG with diabetes mellitus.
- Diabetes is a questionable risk factor for glaucoma. The association may be a result of self-selection into the health care system.
- Smoking[14]
- Omega-3 fatty acids have been associated with a protective effect[14]
- Family history is a definite risk factor.
- Heritable susceptibility has been shown.
- Between 10-20% of patients with glaucoma have a positive family history.
- Ask about family history of glaucoma, especially in first-degree relatives. Family history of glaucoma in a sibling is the greatest risk factor, followed by glaucoma in a parent. Also, ask if glaucoma in other family members resulted in vision loss (the individual may have only had ocular hypertension).
- The Baltimore Eye Survey found that the relative risk of having glaucoma is increased 3.7-fold for individuals who have siblings with POAG.
- Heritable susceptibility (genetics of glaucoma) has been shown for the following:
- POAG - Juvenile onset; genetic linkage mapped to band 1q23[15]
- POAG - Adult onset[16, 17]
- Pigmentary glaucoma - Gene responsible for fragment dispersion syndrome mapped to band 7q35q36[18]
- Pseudoexfoliation
- Aniridia
- Axenfeld-Rieger syndrome
- Primary congenital glaucoma
- Heritable susceptibility has been shown.
- Review of old records - Note previous IOP, cup-to-disc ratios, ocular surgery, and past visual fields. (Caution: Poor agreement and observer variability can occur in disc examinations over time.)
Physical
- IOP
- IOP is a definite and important risk factor for developing glaucomatous damage but is not sufficient for a diagnosis.[19, 20, 13, 21]
- The prevalence of POAG is higher with increasing IOP.
- One tenth of patients with ocular hypertension develop field loss within 10 years.
- Each year, about 1% of all individuals with increased IOP progress to glaucomatous damage.
- As many as 50% of patients with glaucomatous optic neuropathy or visual field changes have IOP of less than 21 mm Hg on initial evaluation.
- Some eyes undergo damage at IOP of less than 18 mm Hg; others tolerate IOP of more than 30 mm Hg.
- A pressure of 10-21 mm Hg is considered normal; a nongaussian distribution occurs with a skew toward higher pressures.
- Diurnal variation
- 2-6 mm Hg - Normal
- Greater than 10 mm Hg - Variation suggestive of glaucoma
- Peak usually occurs in the morning hours.
- IOP measurement
- Goldmann-type applanation tonometry is the criterion standard.
- In patients who are obese, handheld tonometry may be more accurate by minimizing strain to fit to the slit lamp.
- Common pitfalls in IOP measurement
- Too much/too little fluorescence occurs.
- Meridians are not averaged in patients with high astigmatism.
- The upper lid is not held gently.
- Patients should breathe normally.
- Unless dangerously elevated, IOP is checked numerous times before initiating treatment to assess diurnal variation.
- Abnormally thick corneas may result in artificially high IOP measurements by applanation tonometry, while abnormally thin corneas may result in artificially low IOP measurements.
- IOP is a definite and important risk factor for developing glaucomatous damage but is not sufficient for a diagnosis.[19, 20, 13, 21]
- Corneal pachymetry
- The Ocular Hypertension Treatment Study (OHTS) showed central corneal thickness as a significant predictor of the development of POAG.[8, 19]
- Patients with a central corneal thickness of less than 555 µm had a 3 times greater risk of developing POAG than patients with a central corneal thickness of greater than 588 µm.
- Slit lamp examination - Look for signs of secondary causes/risk factors of glaucoma.
- Corneal endothelium
- Krukenberg spindle
- Keratic precipitates
- Pigmentary changes on endothelial cells
- Anterior chamber angle depth
- Identification of narrow occludable depth
- Avoidance of mydriatics in such eyes
- Iris
- Mid iris spokelike transillumination defects (seen in pseudoexfoliation and pigment dispersion)
- Dandrufflike material on pupillary margin and on lens capsule (pseudoexfoliation)
- Neovascularization
- Corneal endothelium
- Gonioscopy - Perform on all patients who are glaucoma suspect, and repeat it periodically. It is especially important in the following cases:
- The chamber shallows, and IOP rises.
- Angle problems (eg, hyperopia, symptoms of subacute/acute angle-closure glaucoma, narrow angle) are evident.
- The patient is diabetic.
- Vein occlusion is present.
- A history of ocular trauma exists.
- Evaluation of angle depth, signs, and risk factors for secondary glaucoma
- Narrow-angle depth
- Angle recession
- Heavy pigmentation of TM (pigment dispersion)
- Patchy pigmentation of TM (pseudoexfoliation)
- Hemorrhage
- Inflammatory changes
- Angle closure
- Peripheral anterior synechiae
- Neovascularization of the angle
- Evaluation of the optic nerve head[22, 23]
- The best examination method is a slit lamp combined with a 60-D, 78-D, or 90-D Hruby lens or a posterior pole lens through a dilated pupil.
- High magnification
- Stereoscopic view
- Excellent illumination
- Special attention to contour and color
- Normal vertical cup-to-disc ratio is 0.3.
- In a normal rim, the inferior portion is thickest, followed by the superior rim.
- Patients with myopia have larger eyes and larger discs and cups.
- Assessing optic nerve damage in small optic discs with minimal cupping may be difficult.[24]
- Large optic discs may appear pathologic when they actually show only physiologic cupping, especially in African Americans.
- Signs of early glaucomatous damage can be subtle.[25]
- Generalized enlargement of cup
- Focal notching
- Superficial splinter hemorrhage
- Asymmetry of cupping between 2 eyes
- Nerve fiber layer dropout
- Asymmetry of neuroretinal rim
- Focal thinning of neuroretinal rim
- Acquired change in disc rim appearance
- Acquired change in retinal nerve fiber layer
- Nerve fiber layer deficit
- Thinning of inferior-temporal rim
- Progressive enlargement of cup
- Vertical elongation of cup
- Cupping to rim margin
- Exposure of lamina cribrosa
- Peripapillary atrophy
- Baring of circumlinear vessels
- Search for other abnormalities that may account for the visual field defect.
- Tilted disc
- Disc drusen
- Optic pits
- Retinal disease
- Optic atrophy
- Document the appearance of the optic nerve head.
- The preferred technique - Baseline stereo disc photographs for future comparison
- Detailed description and drawings
- Automated techniques
- Scanning lasers - Advantages include accurate, reproducible, and patient comfort (nondilated). A disadvantage is the cost (expensive).
- Weinreb et al found that baseline confocal scanning laser ophthalmoscopy Glaucoma Progression Scores, either alone or combined with baseline clinical and demographic factors, can be used to predict the development of primary open-angle glaucoma, and are as effective as stereophotographs in ocular hypertensive patients in predicting the development of primary open-angle glaucoma.[26]
- Polarimetry - Advantages include accurate and reproducible. A disadvantage is the cost (expensive).
- The best examination method is a slit lamp combined with a 60-D, 78-D, or 90-D Hruby lens or a posterior pole lens through a dilated pupil.
- Evaluation of the retinal nerve fiber layer - Look for nerve fiber layer defects/dropout.
- Techniques
- Ophthalmoscopic examination with red-free (green) filter
- Good color photography
- Red-free photography
- Instruments for retinal nerve fiber layer analysis[27]
- Advantage - Most accurate
- Disadvantage – Expensive
- Techniques
- Visual field testing should be normal.
- Absence of visual field defects does not ensure absence of glaucoma.
- As many as 50% of optic nerve fibers in a single optic nerve may be damaged before visual field defects are found by Goldmann perimetry.
- Common pitfalls in visual field testing
- Pupillary diameter should be maximized.
- Correct refraction should be used.
- Patient reliability is limited in some cases.
- Interpretation of visual field testing
- Use comparable tests when comparing fields. For example, one cannot directly compare Swedish interactive thresholding algorithm (SITA) with Fastpac or HVF 30-2 threshold testing.
- If a field defect is detected, ensure that it is reproducible.
- The abnormal points should be contiguous, paralleling the pattern of the nerve fiber layer in an arcuate pattern respecting the horizontal midline.
- The greater the abnormal points and the deeper the defects, the more likely it represents a true scotoma.
- The standard testing strategy used by many ophthalmologists in past evaluations has been HVF 30-2 or 24-2 traditional threshold testing with statistical analysis.
- Humphrey Fastpac - Requires less testing time; decrease in precision of threshold algorithm estimate.
- SITA - Reduces testing time by about 50% without sacrificing accuracy. Less interindividual variability occurs, and gray scale printouts may look lighter.
- Short wavelength automated perimetry (SWAP) - Uses blue target on a yellow background to isolate those visual pathways that are believed to be damaged selectively in early glaucoma. Many studies suggest that it is capable of earlier detection of glaucomatous defects, which may be useful in detecting progression to glaucoma in those patients who are glaucoma suspect and at a high risk.[28, 29] Requires longer testing time with 3-minute adaptation to yellow background.
- Frequency-doubling technology perimetry - Uses a coarse striped grating of rapidly alternating dark and light bands. Takes 4-5 minutes for each eye; screening test takes less than 1 minute. Potential role exists in diagnosing early glaucoma and in detecting moderate-to-advanced glaucoma.[30]
Causes
- Risk factors that are associated with developing glaucomatous damage include the following:
- Elevated IOP
- Suspicious optic nerve head appearance
- Nerve fiber layer defects
- Increasing age
- Family history of glaucoma
- African American ethnicity
- Myopia
- Diabetes mellitus
- Pseudoexfoliation
- Pigment dispersion
- History of ocular trauma with associated angle recession
- History of uveitis
- Glaucoma in one eye
- Narrow anterior chamber angle depth
- Prior eye surgery
- Steroid use
- Migraine headache
- Cardiovascular disease
- Tight neck tie[31]
- The greater the number and the degree of risk factors, the greater the risk of developing glaucoma over time.
- Some risk factors, such as pigment dispersion, increased IOP, suspicious optic nerve head appearance, increasing age, glaucoma in one eye, pseudoexfoliation, a strong family history of glaucoma, and race (ie, African American), are more important than other factors.
Piltz-Seymour JR. Does Your Patient Have Glaucoma?. Review of Ophthalmol. 1999;VI(6):86-99.
Quality of Care Committee, Glaucoma Panel. The Glaucoma Suspect (Preferred Practice Pattern). Amer Acad of Ophthamol Bul. 1995.
Quality of Care Committee, Glaucoma Panel. Primary Open-Angle Glaucoma (Preferred Practice Pattern). Amer Acad of Ophthalmol Bul. 1992.
Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. Jan 1982;100(1):135-46. [Medline].
Rader J, Feuer WJ, Anderson DR. Peripapillary vasoconstriction in the glaucomas and the anterior ischemic optic neuropathies. Am J Ophthalmol. Jan 15 1994;117(1):72-80. [Medline].
Armaly MF, Krueger DE, Maunder L, et al. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol. Dec 1980;98(12):2163-71. [Medline].
Kass MA, Kolker AE, Becker B. Prognostic factors in glaucomatous visual field loss. Arch Ophthalmol. Aug 1976;94(8):1274-6. [Medline].
Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. Jun 2002;120(6):714-20; discussion 829-30. [Medline].
Skalicky SE, Borovik AM, Masselos K, et al. Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy. J Glaucoma. Apr-May 2008;17(3):249; author reply 249-50. [Medline].
Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. Jul 17 1991;266(3):369-74. [Medline].
Varma R, Wang D, Wu C, et al. Four-Year Incidence of Open-Angle Glaucoma and Ocular Hypertension: The Los Angeles Latino Eye Study. Am J Ophthalmol. Apr 27 2012;[Medline].
Leske MC, Connell AM, Wu SY, Hyman LG, Schachat AP. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol. Jul 1995;113(7):918-24. [Medline].
Quigley HA, Enger C, Katz J, Sommer A, Scott R, Gilbert D. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol. May 1994;112(5):644-9. [Medline].
Renard JP, Rouland JF, Bron A, et al. Nutritional, lifestyle and environmental factors in ocular hypertension and primary open-angle glaucoma: an exploratory case-control study. Acta Ophthalmol. Mar 6 2012;[Medline].
Sheffield VC, Stone EM, Alward WL, et al. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat Genet. May 1993;4(1):47-50. [Medline].
Wirtz MK, Samples JR, Kramer PL, et al. Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q. Am J Hum Genet. Feb 1997;60(2):296-304. [Medline]. [Full Text].
Stone EM, Fingert JH, Alward WL, et al. Identification of a gene that causes primary open angle glaucoma. Science. Jan 31 1997;275(5300):668-70. [Medline].
Andersen JS, Pralea AM, DelBono EA, et al. A gene responsible for the pigment dispersion syndrome maps to chromosome 7q35-q36. Arch Ophthalmol. Mar 1997;115(3):384-8. [Medline].
Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. Jun 2002;120(6):701-13; discussion 829-30. [Medline].
Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest Ophthalmol Vis Sci. Feb 1980;19(2):137-52. [Medline].
Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol. Aug 1991;109(8):1090-5. [Medline].
Lichter PR. Variability of expert observers in evaluating the optic disc. Trans Am Ophthalmol Soc. 1976;74:532-72. [Medline]. [Full Text].
Spencer AF, Vernon SA. Comparison of a simple ophthalmoscopic and planimetric measurement of glaucomatous neuroretinal rim areas. J Glaucoma. Jun 1996;5(3):221-2. [Medline].
Jonas JB, Fernandez MC, Naumann GO. Glaucomatous optic nerve atrophy in small discs with low cup-to-disc ratios. Ophthalmology. Sep 1990;97(9):1211-5. [Medline].
Zeyen TG, Caprioli J. Progression of disc and field damage in early glaucoma. Arch Ophthalmol. Jan 1993;111(1):62-5. [Medline].
Weinreb RN, Zangwill LM, Jain S, et al. Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study. Ophthalmology. Sep 2010;117(9):1674-83. [Medline].
Jansonius NM, Heeg GP. The Groningen Longitudinal Glaucoma Study. II. A prospective comparison of frequency doubling perimetry, the GDx nerve fibre analyser and standard automated perimetry in glaucoma suspect patients. Acta Ophthalmol. Jun 2009;87(4):429-32. [Medline].
Johnson CA, Adams AJ, Casson EJ, Brandt JD. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol. May 1993;111(5):645-50. [Medline].
Johnson CA, Adams AJ, Casson EJ, Brandt JD. Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry. Arch Ophthalmol. May 1993;111(5):651-6. [Medline].
Jansonius NM, Heeg GP. The Groningen Longitudinal Glaucoma Study. II. A prospective comparison of frequency doubling perimetry, the GDx nerve fibre analyser and standard automated perimetry in glaucoma suspect patients. Acta Ophthalmol. Jun 2009;87(4):429-32. [Medline].
Bozic M, Hentova Sencanin P, Brankovic A, Marjanovic I, Dordevic Jocic J, Sencanin I. [Effect of a tight necktie on intraocular pressure]. Med Pregl. Jan-Feb 2012;65(1-2):13-7. [Medline].
De Moraes CG, Demirel S, Gardiner SK, et al. Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group. Invest Ophthalmol Vis Sci. 2012;53(4):1704-9. [Medline]. [Full Text].
Higginbotham EJ. Ocular Hypertension Treatment Study. Arch Ophthalmol. Feb 2009;127(2):213-5. [Medline].
Rhee DJ. Preventing glaucoma in a high-risk population: impact and observations of the Ocular Hypertension Treatment Study. Arch Ophthalmol. Feb 2009;127(2):216-8. [Medline].
Doshi A, Singh K. Cost-effective evaluation of the glaucoma suspect. Curr Opin Ophthalmol. Mar 2007;18(2):97-103. [Medline].
Blini M, Rossi GC, Trabucchi G, et al. Ocular hypotensive efficacy and safety of travoprost 0.004% in inadequately controlled primary open-angle glaucoma or ocular hypertension: short-term, multicenter, prospective study. Curr Med Res Opin. Jan 2009;25(1):57-63. [Medline].
Shazly TA, Latina MA, Dagianis JJ, Chitturi S. Effect of Central Corneal Thickness on the Long-Term Outcome of Selective Laser Trabeculoplasty as Primary Treatment for Ocular Hypertension and Primary Open-Angle Glaucoma. Cornea. Apr 19 2012;[Medline].
National Advisory Eye Counsel Vision Research. A National Plan. NIH. 1982;1:12-13.
Print
